Influence of the use of psychotropic drugs on the increase of Escherichia coli resistance
DOI:
https://doi.org/10.56294/saludcyt2024701Keywords:
Escherichia Coli, Gut Microbiota, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Bacterial ResistanceAbstract
Introduction: Escherichia coli is one of the most investigated bacteria due to the diversity of impacts on human health; it can sometimes form new resistant strains through conjugation processes, becoming a real public health problem.
Objective: to evaluate the relationship between prolonged use of psychotropic drugs and increased antimicrobial resistance in Escherichia coli strains.
Methods: a comprehensive literature review was conducted using different databases of scientific importance; including 35 theses, research articles and reviews published in Spanish and English, from 2019 to 2023.
Results: studies of patients under psychotropic treatment with tricyclic antidepressants and selective serotonin reuptake inhibitors for more than 3 months were analyzed; proving the appearance of dysbiosis in the intestinal microbiota.
Conclusion: the appearance of dysbiosis in the intestinal microbiota of patients under treatment with psychotropic drugs such as tricyclic antidepressants and selective serotonin reuptake inhibitors, causes a reduction in beneficial bacteria and favors the necessary environment for an increase in pathogenic gram-negative bacteria with resistant mutated strains, specifically Escherichia coli
References
1. Sánchez Gavilanes Lissette Katherine. Análisis de secuencias de genoma completo de Escherichia coli aisladas de vegetales y comida callejera de Ecuador [Internet]. 2023 [citado 24 de octubre de 2023]. Disponible en: https://repositorio.uta.edu.ec/jspui/handle/123456789/37956
2. Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Unravelling the antimicrobial action of antidepressants on gut commensal microbes. Sci Rep [Internet]. 1 de diciembre de 2020 [citado 8 de noviembre de 2023];10(1). Disponible en: https://www.nature.com/articles/s41598-020-74934-9#ref-CR8
3. Pinto Niño Mónica Andrea. La microbiota intestinal y la disbiosis, relaciones metabólicas a nivel patológico y en la salud. [Internet]. 2022 [citado 25 de octubre de 2023]. Disponible en: https://repositorio.unal.edu.co/bitstream/handle/unal/83775/1022932886.2023.pdf?sequence=6&isAllowed=y
4. Weersma RK, Zhernakova A, Fu J. Interaction between drugs and the gut microbiome [Internet]. Vol. 69, Gut. BMJ Publishing Group; 2020 [citado 25 de octubre de 2023]. p. 1510-9. Disponible en: https://gut.bmj.com/content/gutjnl/69/8/1510.full.pdf
5. Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje AR, et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun [Internet]. 1 de diciembre de 2020 [citado 25 de octubre de 2023];11(1). Disponible en: https://gut.bmj.com/content/69/8/1510
6. Iglesias–vázquez L, Riba GVG, Arija V, Canals J. Composition of gut microbiota in children with autism spectrum disorder: A systematic review and meta-analysis [Internet]. Vol. 12, Nutrients. MDPI AG; 2020 [citado 25 de octubre de 2023]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32192218/
7. Mottawea W, Sultan S, Landau K, Bordenave N, Hammami R. Evaluation of the prebiotic potential of a commercial synbiotic food ingredient on gut microbiota in an ex vivo model of the human colon. Nutrients. 1 de septiembre de 2020;12(9):1-15.
8. Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Evidence of the Dysbiotic Effect of Psychotropics on Gut Microbiota and Capacity of Probiotics to Alleviate Related Dysbiosis in a Model of the Human Colon. Int J Mol Sci. 1 de abril de 2023;24(8).
9. Ait Chait Y, Mottawea W, Tompkins TA, Hammami R. Unravelling the antimicrobial action of antidepressants on gut commensal microbes. Sci Rep. 1 de diciembre de 2020;10(1).
10. Moraczewski J, Awosika AO, Aedma KK. Tricyclic Antidepressants. [Internet]. 2023 [citado 16 de agosto de 2023]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK557791/
11. Thorneloe WF. Psychopharmacologic treatment of obsessive-compulsive disorder. Vol. 77, Journal of the Medical Association of Georgia. 1988. p. 825-6.
12. Chu A, Wadhwa R. Inhibidores selectivos de la recaptación de serotonina. [Internet]. 2023 [citado 30 de abril de 2023]. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK554406/
13. Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis [Internet]. Vol. 2021, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2021 [citado 25 de octubre de 2023]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34029378/
14. Ding P, Lu J, Wang Y, Schembri MA, Guo J. Antidepressants promote the spread of antibiotic resistance via horizontally conjugative gene transfer. Environ Microbiol. 1 de noviembre de 2022;24(11):5261-76.
15. Wang Y, Yu Z, Ding P, Lu J, Mao L, Ngiam L, et al. Antidepressants can induce mutation and enhance persistence toward multiple antibiotics. Proc Natl Acad Sci U S A. 31 de enero de 2023;120(5).
16. Huemer M, Mairpady Shambat S, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence—Implications for human health and treatment perspectives. EMBO Rep. 3 de diciembre de 2020;21(12).
17. Marín González Patricia. Efecto de la Microbiota Intestinal sobre la Biodisponibilidad de los Fármacos [Internet]. 2022 [citado 16 de noviembre de 2023]. Disponible en: https://repositorio.xoc.uam.mx/jspui/retrieve/4db4885e-6f50-43d7-b102-3d986c59517f/250795.pdf
18. Negeri AA, Mamo H, Gahlot DK, Gurung JM, Seyoum ET, Francis MS. Characterization of plasmids carrying bla CTX-M genes among extra-intestinal Escherichia coli clinical isolates in Ethiopia. Sci Rep. 1 de diciembre de 2023;13(1).
19. Lukić I, Getselter D, Ziv O, Oron O, Reuveni E, Koren O, et al. Antidepressants affect gut microbiota and Ruminococcus flavefaciens is able to abolish their effects on depressive-like behavior. Transl Psychiatry [Internet]. 1 de diciembre de 2019 [citado 8 de noviembre de 2023];9(1). Disponible en: https://pubmed.ncbi.nlm.nih.gov/30967529/
20. Lyte M, Daniels KM, Schmitz-Esser S. Fluoxetine-induced alteration of murine gut microbial community structure: evidence for a microbial endocrinology-based mechanism of action responsible for fluoxetine-induced side effects. PeerJ [Internet]. 9 de enero de 2019;7:e6199. Disponible en: https://peerj.com/articles/6199
21. Bonilla-Jaime H, Sánchez-Salcedo JA, Estevez-Cabrera MM, Molina-Jiménez T, Cortes-Altamirano JL, Alfaro-Rodríguez A. Depression and Pain: Use of Antidepressants. Curr Neuropharmacol [Internet]. 21 de junio de 2021 [citado 25 de octubre de 2023];20(2):384-402. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34151765/
22. Martín E, Área De Toxicología L. Uso de emulsiones lipídicas en intoxicación por antidepresivos tricíclicos desde el servicio de urgencias: Una serie de casos [Internet]. 2022. Disponible en: http://revista.aetox.es
23. Furukawa TA, Cipriani A, Cowen PJ, Leucht S, Egger M, Salanti G. Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry [Internet]. 1 de julio de 2019 [citado 25 de octubre de 2023];6(7):601-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31178367/
24. Brown JVE, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E, et al. Antidepressant treatment for postnatal depression [Internet]. Vol. 2021, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2021 [citado 25 de octubre de 2023]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33580709/
25. Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, et al. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials. Mol Psychiatry [Internet]. 1 de febrero de 2022 [citado 25 de octubre de 2023];27(2):1136-44. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34642461/
26. Rink L, Adams A, Braun C, Bschor T, Kuhr K, Baethge C. Dose-response relationship in selective serotonin and norepinephrine reuptake inhibitors in the treatment of major depressive disorder: A meta-analysis and network meta-analysis of randomized controlled trials [Internet]. Vol. 91, Psychotherapy and Psychosomatics. S. Karger AG; 2022 [citado 25 de octubre de 2023]. p. 84-93. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34965534/
27. Ng QX, Lim YL, Yaow CYL, Ng WK, Thumboo J, Liew TM. Effect of Probiotic Supplementation on Gut Microbiota in Patients with Major Depressive Disorders: A Systematic Review [Internet]. Vol. 15, Nutrients. Multidisciplinary Digital Publishing Institute (MDPI); 2023 [citado 8 de noviembre de 2023]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/36986088/
28. Luis González Á, Roth EP. Optimización de un protocolo de conjugación bacteriana in vitro de plásmidos portadores de genes de resistencia antibiótica [Internet]. 2022 [citado 8 de noviembre de 2023]. Disponible en: https://riull.ull.es/xmlui/handle/915/28462
29. Dimitriu Tatiana. Evolution of horizontal transmission in antimicrobial resistance plasmids [Internet]. Vol. 168, Microbiology (United Kingdom). Microbiology Society; 2022 [citado 13 de noviembre de 2023]. Disponible en: https://www.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.001214
30. Camacho Luis. Resistencia bacteriana, una crisis actual [Internet]. 2023 [citado 13 de noviembre de 2023]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541255/
31. Knuesel T, Mohajeri MH. The role of the gut microbiota in the development and progression of major depressive and bipolar disorder [Internet]. Vol. 14, Nutrients. MDPI; 2022 [citado 8 de noviembre de 2023]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35010912/
32. Zhang S, Lu B, Wang G. The role of gut microbiota in the pathogenesis and treatment of postpartum depression. Ann Gen Psychiatry [Internet]. 27 de septiembre de 2023;22(1):36. Disponible en: https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/s12991-023-00469-8
33. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 12 de febrero de 2022;399(10325):629-55.
34. La humanidad enfrenta un desastre: la resistencia antimicrobiana [Internet]. 2021. Disponible en: https://www.researchgate.net/publication/354371365
35. Barbé García Jordi. Actualización de conceptos de Microbiología para el Bachillerato y Ciclos Formativos de Grado Superior [Internet]. 2022 [citado 13 de noviembre de 2023]. Disponible en: https://www.semicrobiologia.org/wp-content/uploads/2023/01/Actualizacion-conceptos-Microbiologia-v20230110.pdf
Published
Issue
Section
License
Copyright (c) 2024 Dayanara Tifane Zambrano Zambrano, Lourdes Gioconda Tabares Rosero (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
